Previous Close | 26.39 |
Open | 26.93 |
Bid | 0.00 x 800 |
Ask | 0.00 x 800 |
Day's Range | 26.87 - 27.22 |
52 Week Range | 19.49 - 32.91 |
Volume | |
Avg. Volume | 813,711 |
Market Cap | 25.329B |
Beta (5Y Monthly) | 0.79 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.51 |
Earnings Date | Feb 03, 2025 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | May 12, 2022 |
1y Target Est | 34.50 |
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today released the second set of Asia Pacific (APAC) findings of its Future Health Index (FHI) 2024 report: Better care for more people. The ninth edition of the report, which surveyed nearly 3,000 healthcare leaders in 14 countries, including Australia, Indonesia, and Singapore, shows that APAC is leading the charge when it comes to sustainable healthcare, with healthcare leaders looking to invest in further sustainable
MR technologist reviews icometrix AI report on the Philips BlueSeal MRI console MR technologist reviews neuro images in icometrix AI reporting tool November 25, 2024icometrix’ FDA-cleared quantitative brain solution for neurological conditions including Alzheimer’s and multiple sclerosis is seamlessly integrated into Philips next generation BlueSeal MR scanners, and will be deployed in its comprehensive informatics platformAmsterdam, the Netherlands and Leuven, Belgium – Royal Philips (NYSE: PHG